ArticleCureus2025
Acute Liver Injury of Unclear Etiology: A Case of Alcohol-Associated Steatohepatitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 37-year-old female was hospitalized for acute liver injury, presenting a diagnostic challenge that ultimately led to a diagnosis of alcohol-associated steatohepatitis (ASH). Steatohepatitis is a state of liver inflammation with fat accumulation and has several potential etiologies, including metabolic dysfunction-associated, alcohol-associated, drug-induced, autoimmune, and viral causes. A definitive diagnosis often requires a thorough clinical history, laboratory and imaging studies, and, in some cases, a liver biopsy. Our patient, with a history of gastroesophageal reflux disease, alcohol-use disorder, obesity, and systemic lupus erythematosus, presented with a one-week history of abdominal pain, jaundice, conjunctival icterus, and hepatomegaly without altered mental status. Laboratory results showed a total bilirubin of 12.5 mg/dL, aspartate aminotransferase of 237 U/L, alanine aminotransferase of 129 U/L, alkaline phosphatase of 424 U/L, and an international normalized ratio of 1.2. Right upper quadrant ultrasound revealed no biliary obstruction. Viral and autoimmune panels, as well as immunoglobulins, were unremarkable. Ceruloplasmin was low (0.09 g/L), 24-hour urinary copper was elevated (40 µg/24 hour), and slit-lamp examination was negative for Kayser-Fleischer rings. Liver biopsy revealed severe steatosis with prominent Mallory-Denk bodies, bridging fibrosis, and portal tract inflammatory infiltrates. These histologic features, together with a positive phosphatidylethanol test, led to the diagnosis of ASH. This case highlights an interesting diagnostic challenge of acute liver injury. Although ceruloplasmin was low and 24-hour urinary copper was elevated, these levels did not meet the diagnostic criteria for Wilson's disease. Liver biopsy suggested ASH, despite the patient reporting cessation of alcohol use. In cases of acute liver injury where history, labs, and imaging studies are inconclusive, liver biopsy is crucial for diagnosis. Treatment for ASH includes abstinence from alcohol and corticosteroids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.